Pharma Journalist - Page 846 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Geisinger & Boehringer Ingelheim to develop risk-prediction model for type 2 diabetes health outcomes

Catalent sings agreement to acquire Cook Pharmica for $950 Million

Nivolumab now available for lung cancer after company offers NICE new CDF deal

Most common ear infections should not be treated with antibiotics, says NICE

Recipharm & Roche sign agreement to manufacture a range of solid dose products

Pfizer Goes To Court To Allow Competition For Biologics And Expand Options For Patients

EC approves Novartis’s Rydapt for two indications in rare, hard-to-treat cancers

AVEO Oncology and EUSA Pharma Announce TiNivo Combination Study Opt-in

GSK, AstraZeneca and Labcyte Form Alliance to Develop Acoustic Mass Spectrometry

MilliporeSigma Opens China’s First BioReliance End-to-End Biodevelopment Center in Shanghai